Reversible posterior leukoencephalopathy syndrome associated with bevacizumab/doxorubicin regimen

Br J Clin Pharmacol. 2008 May;65(5):793-4. doi: 10.1111/j.1365-2125.2008.03119.x. Epub 2008 Feb 15.
No abstract available

Publication types

  • Case Reports
  • Letter

MeSH terms

  • Adult
  • Antibodies, Monoclonal / administration & dosage
  • Antibodies, Monoclonal, Humanized
  • Antineoplastic Combined Chemotherapy Protocols / adverse effects*
  • Bevacizumab
  • Breast Neoplasms / drug therapy*
  • Doxorubicin / administration & dosage
  • Female
  • Humans
  • Posterior Leukoencephalopathy Syndrome / chemically induced*

Substances

  • Antibodies, Monoclonal
  • Antibodies, Monoclonal, Humanized
  • Bevacizumab
  • Doxorubicin